日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

DNA Repair gene alterations and efficacy from gemcitabine and nab-paclitaxel with/without durvalumab and tremelimumab in metastatic pancreatic ductal adenocarcinoma

DNA修复基因改变及吉西他滨和白蛋白紫杉醇联合/不联合度伐利尤单抗和曲美木单抗治疗转移性胰腺导管腺癌的疗效

Renouf, Daniel J; Topham, James T; Loree, Jonathan M; Schaeffer, David F; Knox, Jennifer J; Kavan, Petr; Jonker, Derek; Welch, Stephen; Couture, Felix; Lemay, Frederic; Tehfe, Mustapha; Harb, Mohammed; Aucoin, Nathalie; Ko, Yoo-Joung; Tang, Patricia A; Ramjeesingh, Ravi; Meyers, Brandon M; Kim, Christina A; Du, Pan; Jia, Shidong; Karasinska, Joanna M; Gill, Sharlene; Tu, Dongsheng; O'Callaghan, Chris J

Salsalate improves the anti-tumor efficacy of lenvatinib in MASH-driven hepatocellular carcinoma.

水杨酸盐可提高乐伐替尼对 MASH 驱动的肝细胞癌的抗肿瘤疗效

Tsakiridis Evangelia E, Ahmadi Elham, Gautam Jaya, Hannah She Yi Ran, Fayyazi Russta, Lally James S V, Wang Simon, Di Pastena Fiorella, Valvano Celina M, Del Rosso Daniel, Biziotis Olga-Demetra, Meyers Brandon, Muti Paola, Tsakiridis Theodoros, Steinberg Gregory R

Role of immune checkpoint inhibitor combinations in resectable and unresectable, embolization-eligible hepatocellular carcinoma

免疫检查点抑制剂联合疗法在可切除和不可切除、适合栓塞治疗的肝细胞癌中的作用

Meyers, Brandon M; Lim, Howard J; Brahmania, Mayur; Liu, Dave M; Tam, Vincent C; McLeod, Deanna; Ramjeesingh, Ravi; Knox, Jennifer J; Vogel, Arndt

Prognostic factors in advanced incurable HNSCC patients on palliative-intent immunotherapy-based regimen

晚期不可治愈的头颈部鳞状细胞癌患者接受姑息性免疫治疗方案的预后因素

Al Maqrashi, Zainab; Bradbury, Michelle; Chan, Sze Wah Samuel; AlHarbi, Yazeed; Fazzari, Francesco; Gabara, Adam; Faisal, Haseeb; Sadeghian, Shadi; Pond, Gregory R; Meyers, Brandon M; Kartolo, Adi; Coschi, Courtney

Impact of pre-operative abdominal MRI on survival for patients with resected pancreatic carcinoma: a population-based study

术前腹部MRI对胰腺癌切除患者生存率的影响:一项基于人群的研究

Alaref, Amer; Siltamaki, Dylan; Cerasuolo, Joshua O; Akhtar-Danesh, Noori; Caswell, Joseph M; Serrano, Pablo E; Meyers, Brandon M; Savage, David W; Nelli, Jennifer; Patlas, Michael; Alabousi, Abdullah; Siddiqui, Rabail; van der Pol, Christian B

Concurrent immunotherapy and radiation in cisplatin-ineligible patients with HNSCC: a systematic review & meta-analysis

免疫疗法联合放射疗法治疗不适合顺铂治疗的头颈部鳞状细胞癌患者:系统评价和荟萃分析

Chan, Sze Wah Samuel; Al Maqrashi, Zainab Ali Amer; Young, Jack; Kim, Do-Hoon; Pond, Gregory; Meyers, Brandon M; Kartolo, Adi

The CCTG PA.7 phase II trial of gemcitabine and nab-paclitaxel with or without durvalumab and tremelimumab as initial therapy in metastatic pancreatic ductal adenocarcinoma

CCTG PA.7 II期临床试验,评估吉西他滨联合白蛋白紫杉醇,或不联合度伐利尤单抗和曲美木单抗作为转移性胰腺导管腺癌一线治疗的疗效

Renouf, Daniel J; Loree, Jonathan M; Knox, Jennifer J; Topham, James T; Kavan, Petr; Jonker, Derek; Welch, Stephen; Couture, Felix; Lemay, Frederic; Tehfe, Mustapha; Harb, Mohammed; Aucoin, Nathalie; Ko, Yoo-Joung; Tang, Patricia A; Ramjeesingh, Ravi; Meyers, Brandon M; Kim, Christina A; Du, Pan; Jia, Shidong; Schaeffer, David F; Gill, Sharlene; Tu, Dongsheng; O'Callaghan, Chris J

Toxicity Profiles of Systemic Therapies for Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-analysis

晚期肝细胞癌全身治疗的毒性特征:系统评价和荟萃分析

Griffiths, Christopher D; Zhang, Betty; Tywonek, Kasia; Meyers, Brandon M; Serrano, Pablo E

Assessing the impact of COVID-19 on liver cancer management (CERO-19)

评估 COVID-19 对肝癌治疗的影响 (CERO-19)

Muñoz-Martínez, Sergio; Sapena, Victor; Forner, Alejandro; Nault, Jean-Charles; Sapisochin, Gonzalo; Rimassa, Lorenza; Sangro, Bruno; Bruix, Jordi; Sanduzzi-Zamparelli, Marco; Hołówko, Wacław; El Kassas, Mohamed; Mocan, Tudor; Bouattour, Mohamed; Merle, Philippe; Hoogwater, Frederik J H; Alqahtani, Saleh A; Reeves, Helen L; Pinato, David J; Giorgakis, Emmanouil; Meyer, Tim; Villadsen, Gerda Elisabeth; Wege, Henning; Salati, Massimiliano; Mínguez, Beatriz; Di Costanzo, Giovan Giuseppe; Roderburg, Christoph; Tacke, Frank; Varela, María; Galle, Peter R; Alvares-da-Silva, Mario Reis; Trojan, Jörg; Bridgewater, John; Cabibbo, Giuseppe; Toso, Christian; Lachenmayer, Anja; Casadei-Gardini, Andrea; Toyoda, Hidenori; Lüdde, Tom; Villani, Rosanna; Matilla Peña, Ana María; Guedes Leal, Cassia Regina; Ronzoni, Monica; Delgado, Manuel; Perelló, Christie; Pascual, Sonia; Lledó, José Luis; Argemi, Josepmaria; Basu, Bristi; da Fonseca, Leonardo; Acevedo, Juan; Siebenhüner, Alexander R; Braconi, Chiara; Meyers, Brandon M; Granito, Alessandro; Sala, Margarita; Rodríguez-Lope, Carlos; Blaise, Lorraine; Romero-Gómez, Manuel; Piñero, Federico; Gomez, Dhanny; Mello, Vivianne; Pinheiro Alves, Rogerio Camargo; França, Alex; Branco, Fernanda; Brandi, Giovanni; Pereira, Gustavo; Coll, Susanna; Guarino, Maria; Benítez, Carlos; Anders, Maria Margarita; Bandi, Juan C; Vergara, Mercedes; Calvo, Mariona; Peck-Radosavljevic, Markus; García-Juárez, Ignacio; Cardinale, Vincenzo; Lozano, Mar; Gambato, Martina; Okolicsanyi, Stefano; Morales-Arraez, Dalia; Elvevi, Alessandra; Muñoz, Alberto E; Lué, Alberto; Iavarone, Massimo; Reig, Maria

The Cost-Effectiveness of Lenvatinib in the Treatment of Advanced or Unresectable Hepatocellular Carcinoma from a Canadian Perspective

从加拿大视角分析乐伐替尼治疗晚期或不可切除肝细胞癌的成本效益

Meyers, Brandon M; Vogel, Arndt; Marotta, Paul; Kavan, Petr; Kamboj, Laveena; Pan, Janice; Geadah, Marc; Trueman, David; Sabapathy, Suthakar